160 related articles for article (PubMed ID: 31567943)
61. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
62. [Preventive surgery for familial adenomatous polyposis coli].
Kadmon M
Chirurg; 2005 Dec; 76(12):1125-34. PubMed ID: 16323029
[TBL] [Abstract][Full Text] [Related]
63. Assessing barriers to a rational chemoprevention trial design in young patients with familial adenomatous polyposis.
Wood JP; Howells LM; Brown K; Thomas AL
Eur J Cancer Prev; 2017 Jul; 26(4):277-284. PubMed ID: 27128580
[TBL] [Abstract][Full Text] [Related]
64. [Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas].
Cai SR; Yu JK; Jiang WZ; Zhang SZ; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):192-5. PubMed ID: 19615258
[TBL] [Abstract][Full Text] [Related]
65. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis.
van Duijvendijk P; Vasen HF; Bertario L; Bülow S; Kuijpers JH; Schouten WR; Guillem JG; Taat CW; Slors JF
J Gastrointest Surg; 1999; 3(3):325-30. PubMed ID: 10481126
[TBL] [Abstract][Full Text] [Related]
66. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis.
Burt RW; Leppert MF; Slattery ML; Samowitz WS; Spirio LN; Kerber RA; Kuwada SK; Neklason DW; Disario JA; Lyon E; Hughes JP; Chey WY; White RL
Gastroenterology; 2004 Aug; 127(2):444-51. PubMed ID: 15300576
[TBL] [Abstract][Full Text] [Related]
67. Colorectal cancer in familial adenomatous polyposis.
Jang YS; Steinhagen RM; Heimann TM
Dis Colon Rectum; 1997 Mar; 40(3):312-6. PubMed ID: 9118746
[TBL] [Abstract][Full Text] [Related]
68. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients.
Yamaguchi T; Ishida H; Ueno H; Kobayashi H; Hinoi T; Inoue Y; Ishida F; Kanemitsu Y; Konishi T; Tomita N; Matsubara N; Watanabe T; Sugihara K
Jpn J Clin Oncol; 2016 Apr; 46(4):310-5. PubMed ID: 26819281
[TBL] [Abstract][Full Text] [Related]
69. Gastroduodenal lesions in familial adenomatous polyposis.
Kashiwagi H; Spigelman AD
Surg Today; 2000; 30(8):675-82. PubMed ID: 10955728
[TBL] [Abstract][Full Text] [Related]
70. Attenuated familial adenomatous polyposis manifests as autosomal dominant late-onset colorectal cancer.
Ibrahim A; Barnes DR; Dunlop J; Barrowdale D; Antoniou AC; Berg JN
Eur J Hum Genet; 2014 Nov; 22(11):1330-3. PubMed ID: 24549056
[TBL] [Abstract][Full Text] [Related]
71. Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.
Casellas-Cabrera N; Díaz-Algorri Y; Carlo-Chévere VJ; González-Pons M; Rodríguez-Mañón N; Pérez-Mayoral J; Bertrán-Rodríguez C; Soto-Salgado M; Giardiello FM; Rodríguez-Quilichini S; Cruz-Correa M
Fam Cancer; 2016 Apr; 15(2):267-74. PubMed ID: 26690363
[TBL] [Abstract][Full Text] [Related]
72. Long-term compliance with endoscopic surveillance for familial adenomatous polyposis.
Douma KF; Bleiker EM; Aaronson NK; Cats A; Gerritsma MA; Gundy CM; Vasen HF
Colorectal Dis; 2010 Dec; 12(12):1198-207. PubMed ID: 19604286
[TBL] [Abstract][Full Text] [Related]
73. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.
Bertario L; Russo A; Sala P; Varesco L; Giarola M; Mondini P; Pierotti M; Spinelli P; Radice P;
J Clin Oncol; 2003 May; 21(9):1698-707. PubMed ID: 12721244
[TBL] [Abstract][Full Text] [Related]
74. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.
Chen CS; Phillips KD; Grist S; Bennet G; Craig JE; Muecke JS; Suthers GK
Fam Cancer; 2006; 5(4):397-404. PubMed ID: 16944273
[TBL] [Abstract][Full Text] [Related]
75. Surveillance using capsule endoscopy is safe in post-colectomy patients with familial adenomatous polyposis: a prospective Japanese study.
Matsumoto M; Nakajima T; Kakugawa Y; Sakamoto T; Kuribayashi S; Otake Y; Matsuda T; Kanemitsu Y; Taniguchi H; Saito Y
Fam Cancer; 2016 Jan; 15(1):75-83. PubMed ID: 26450841
[TBL] [Abstract][Full Text] [Related]
76. Comparison of dysplastic fundic gland polyps in patients with and without familial adenomatous polyposis.
Straub SF; Drage MG; Gonzalez RS
Histopathology; 2018 Jun; 72(7):1172-1179. PubMed ID: 29436014
[TBL] [Abstract][Full Text] [Related]
77. Frequency and severity of ileal adenomas in familial adenomatous polyposis after colectomy.
Moussata D; Nancey S; Lapalus MG; Prost B; Chavaillon A; Bernard G; Ponchon T; Saurin JC
Endoscopy; 2008 Feb; 40(2):120-5. PubMed ID: 18067065
[TBL] [Abstract][Full Text] [Related]
78. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.
Björk J; Akerbrant H; Iselius L; Alm T; Hultcrantz R
Scand J Gastroenterol; 1999 Dec; 34(12):1230-5. PubMed ID: 10636071
[TBL] [Abstract][Full Text] [Related]
79. Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients.
Ishikawa H; Mutoh M; Abe T; Nakajima T; Takeuchi Y; Ezoe Y; Wakabayashi K; Doyama H; Sakai T
Pharmacology; 2019; 104(1-2):51-56. PubMed ID: 31067545
[TBL] [Abstract][Full Text] [Related]
80. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
